These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25544044)

  • 1. Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.
    Zeller S; Choi CS; Uchil PD; Ban HS; Siefert A; Fahmy TM; Mothes W; Lee SK; Kumar P
    Chem Biol; 2015 Jan; 22(1):50-62. PubMed ID: 25544044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA.
    Ullah I; Chung K; Beloor J; Kim J; Cho M; Kim N; Lee KY; Kumar P; Lee SK
    J Drug Target; 2017 Apr; 25(4):320-329. PubMed ID: 27820977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
    Nakase I; Tanaka G; Futaki S
    Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake Mechanism and Direct Translocation of a New CPP for siRNA Delivery.
    Pan R; Xu W; Ding Y; Lu S; Chen P
    Mol Pharm; 2016 Apr; 13(4):1366-74. PubMed ID: 26937821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
    Ma DX; Shi NQ; Qi XR
    Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid DNA delivery by arginine-rich cell-penetrating peptides containing unnatural amino acids.
    Kato T; Yamashita H; Misawa T; Nishida K; Kurihara M; Tanaka M; Demizu Y; Oba M
    Bioorg Med Chem; 2016 Jun; 24(12):2681-7. PubMed ID: 27132868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics.
    Lönn P; Kacsinta AD; Cui XS; Hamil AS; Kaulich M; Gogoi K; Dowdy SF
    Sci Rep; 2016 Sep; 6():32301. PubMed ID: 27604151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.
    Tuttolomondo M; Ditzel HJ
    Methods Mol Biol; 2021; 2282():353-376. PubMed ID: 33928584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Understanding of Physicochemical Mechanisms for Cell Membrane Penetration of Arginine-rich Cell Penetrating Peptides: Role of Glycosaminoglycan Interactions.
    Takechi-Haraya Y; Saito H
    Curr Protein Pept Sci; 2018; 19(6):623-630. PubMed ID: 29332576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane depolarization reveals endosomal escape incapacity of cell-penetrating peptides.
    Serulla M; Anees P; Hallaj A; Trofimenko E; Kalia T; Krishnan Y; Widmann C
    Eur J Pharm Biopharm; 2023 Mar; 184():116-124. PubMed ID: 36709921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
    Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
    Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
    Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
    Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
    Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
    J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlocking Endosomal Entrapment with Supercharged Arginine-Rich Peptides.
    Najjar K; Erazo-Oliveras A; Mosior JW; Whitlock MJ; Rostane I; Cinclair JM; Pellois JP
    Bioconjug Chem; 2017 Dec; 28(12):2932-2941. PubMed ID: 29065262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
    Gooding M; Browne LP; Quinteiro FM; Selwood DL
    Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation of cell-penetrating peptides across the plasma membrane is controlled by cholesterol and microenvironment created by membranous proteins.
    Pae J; Säälik P; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
    J Control Release; 2014 Oct; 192():103-13. PubMed ID: 25016968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Penetrating Peptides Escape the Endosome by Inducing Vesicle Budding and Collapse.
    Sahni A; Qian Z; Pei D
    ACS Chem Biol; 2020 Sep; 15(9):2485-2492. PubMed ID: 32786250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.